Phenglutarimide is an anticonvulsant medication used to treat seizures, especially in people with epilepsy. It is also sometimes used for treating bipolar disorder. It works by stabilizing electrical activity in the brain to prevent seizures. Common side effects include dizziness, headache, fatigue, and nausea.
Phenglutarimide was an antiparkinsonian medication used to treat symptoms of Parkinson's disease [Wikipedia, Phenglutarimide]. Here's a breakdown of its key characteristics:
- Function: Worked as an anticholinergic, meaning it blocked the action of the acetylcholine neurotransmitter.
- Benefits: Aimed to improve tremors, rigidity, and slowness associated with Parkinson's disease.
- Current Status: No longer a common treatment due to the availability of safer and more effective medications.
Reasons for Phenglutarimide's Decline:
- Side Effects: Anticholinergics can cause side effects like dry mouth, constipation, blurred vision, confusion, and hallucinations, especially in older adults.
- Alternative Medications: Levodopa, carbidopa, and dopamine agonists are now preferred for managing Parkinson's disease as they offer better efficacy and fewer side effects.
Anatomical Therapeutic Chemical Classification
N - Nervous system
N04 Anti-parkinson drugs
N04A - Anticholinergic agents
N04AA Tertiary amines
ATC Code
External Links
Phenglutarimide